These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20979170)

  • 21. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic glioma warranting treatment in children.
    Kaufman LM; Doroftei O
    Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optic glioma in children with type 1 neurofibromatosis].
    Ben-Arush M; Goldberg H; Kuten A; Guilbord J; el-Hassid R
    Harefuah; 1998 Oct; 135(7-8):264-7, 336. PubMed ID: 9885670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.
    Jaing TH; Lin KL; Tsay PK; Hsueh C; Hung PC; Wu CT; Tseng CK
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):222-4. PubMed ID: 18376285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study.
    Saeed P; Blank L; Selva D; Wolbers JG; Nowak PJ; Geskus RB; Weis E; Mourits MP; Rootman J
    Br J Ophthalmol; 2010 May; 94(5):564-8. PubMed ID: 20447964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
    J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.
    Pilling RF; Lloyd IC; Huson S
    Eye (Lond); 2010 Oct; 24(10):1603-5. PubMed ID: 20689568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
    No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracranial visual pathway gliomas in children with neurofibromatosis.
    Packer RJ; Bilaniuk LT; Cohen BH; Braffman BH; Obringer AC; Zimmerman RA; Siegel KR; Sutton LN; Savino PJ; Zackai EH
    Neurofibromatosis; 1988; 1(4):212-22. PubMed ID: 3152473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
    Laithier V; Grill J; Le Deley MC; Ruchoux MM; Couanet D; Doz F; Pichon F; Rubie H; Frappaz D; Vannier JP; Babin-Boilletot A; Sariban E; Chastagner P; Zerah M; Raquin MA; Hartmann O; Kalifa C;
    J Clin Oncol; 2003 Dec; 21(24):4572-8. PubMed ID: 14673044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
    Arvold ND; Lessell S; Bussiere M; Beaudette K; Rizzo JF; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1166-72. PubMed ID: 19406585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual function and optic pathway glioma: a critical response.
    Gutmann DH; Avery R; Ferner RE; Listernick R
    JAMA Ophthalmol; 2013 Jan; 131(1):120-1. PubMed ID: 23307228
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology.
    Falsini B; Chiaretti A; Barone G; Piccardi M; Pierri F; Colosimo C; Lazzareschi I; Ruggiero A; Parisi V; Fadda A; Balestrazzi E; Riccardi R
    Neurorehabil Neural Repair; 2011; 25(6):512-20. PubMed ID: 21444653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
    PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
    Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
    Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual acuity in children with glaucoma.
    Kargi SH; Koc F; Biglan AW; Davis JS
    Ophthalmology; 2006 Feb; 113(2):229-38. PubMed ID: 16406536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.